Valuation: Amgen Inc.

Market Cap 223B 200B 186B 169B 318B 21,603B 321B 2,237B 874B 10,987B 838B 820B 35,320B P/E 2026 *
26.1x
P/E 2027 * 23.4x
Enterprise Value 265B 237B 221B 201B 378B 25,617B 380B 2,653B 1,036B 13,028B 994B 973B 41,882B EV / Sales 2026 *
6.8x
EV / Sales 2027 * 6.42x
Free-Float
99.77%
Yield 2026 *
2.44%
Yield 2027 * 2.58%
1 day+2.60%
1 week-2.00%
Current month-2.00%
1 month-5.52%
3 months+12.22%
6 months+21.49%
Current year+26.20%
1 week 396.01
Extreme 396.01
415.79
1 month 374.46
Extreme 374.46
426.59
Current year 318.21
Extreme 318.21
447.03
1 year 288
Extreme 288
447.03
3 years 249.7
Extreme 249.7001
447.03
5 years 198.64
Extreme 198.64
447.03
10 years 133.64
Extreme 133.64
447.03
Manager TitleAgeSince
Chief Executive Officer 63 01/05/2012
Director of Finance/CFO 62 13/05/2010
Chief Tech/Sci/R&D Officer 57 01/06/2023
Director TitleAgeSince
Chairman 63 01/01/2013
Director/Board Member 65 01/01/2012
Director/Board Member 71 01/01/2012
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Other

Chief Financial Officer

34,061 0.0063%
13/08/26 Exercice

Executive/Senior Manager

3,756 0.0007%
07/08/26 Free

Director

85 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.60%-2.00%+39.77%+54.44% 218B
+2.70%+2.73%+40.91%+110.31% 1,032B
+1.44%-2.38%+36.83%+63.95% 614B
+1.75%+3.73%+16.55%+83.05% 471B
+0.60%-1.73%+62.98%+37.46% 350B
+2.92%+3.12%+24.78%+45.10% 337B
+2.42%+0.05%+14.13%+35.80% 268B
+1.86%-0.81%-4.69%+12.20% 246B
+1.82%-1.48%+25.75%+96.48% 179B
+3.40%+0.28%-32.42%-60.33% 164B
Average +1.65%-1.29%+22.46%+47.85% 387.85B
Weighted average by Cap. +0.92%-0.56%+29.29%+65.06%

Financials

2026 *2027 *
Net sales 38.94B 34.79B 32.46B 29.48B 55.53B 3,767B 55.94B 390B 152B 1,916B 146B 143B 6,158B 40.34B 36.04B 33.63B 30.54B 57.52B 3,902B 57.95B 404B 158B 1,985B 151B 148B 6,380B
Net income 8.58B 7.67B 7.15B 6.5B 12.24B 830B 12.33B 85.95B 33.58B 422B 32.21B 31.52B 1,357B 9.39B 8.39B 7.83B 7.11B 13.39B 909B 13.49B 94.09B 36.76B 462B 35.26B 34.5B 1,486B
Net Debt 41.5B 37.08B 34.59B 31.42B 59.17B 4,014B 59.62B 416B 162B 2,041B 156B 152B 6,563B 35.77B 31.96B 29.82B 27.09B 51.02B 3,461B 51.4B 358B 140B 1,760B 134B 131B 5,658B
Projected Income Statement - Annual - Amgen Inc.
Logo Amgen Inc.
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (95.8%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other 4.2%): primarily royalties. The United States account for 71.9% of net sales.
Employees
31,500
Date Price Change Volume
07/10/26 $413.08 +2.60% 2,236,602
06/10/26 $402.60 -0.09% 2,036,870
05/10/26 $402.98 -0.01% 3,104,125
02/10/26 $403.04 -1.04% 3,510,312
01/10/26 $407.27 -3.38% 2,501,030
Trader
Investor
Global
Quality
ESG MSCI
BBB
Ratings Surperformance© - Amgen Inc.
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
34
Last Close Price
413.08USD
Average target price
391.46USD
Spread / Average Target
-5.23%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Amgen Inc.
  1. Stock Market
  2. Stocks
  3. AMGN Stock